Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathology and breast screening.

C W Elston1, I O Ellis

  • 1Department of Pathology, City Hospital, Nottingham, UK.

Histopathology
|February 1, 1990
PubMed
Summary
This summary is machine-generated.

The UK

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Calpain system protein expression in basal-like and triple-negative invasive breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same author

A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same author

Tumour-infiltrating macrophages and clinical outcome in breast cancer.

Journal of clinical pathology·2011
Same author

Long-term (37 years) clinical outcome of older women with early operable primary breast cancer managed in a dedicated clinic.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same author

Optimising the management of primary breast cancer in older women - a report of a multi-disciplinary study day.

Breast (Edinburgh, Scotland)·2011
Same author

Pathological and mammographic prognostic factors for screen detected cancers in a multi-centre randomised, controlled trial of mammographic screening in women from age 40 to 48 years.

Breast (Edinburgh, Scotland)·2011
Same journal

TROP2 immunoreactivity in pulmonary large cell neuroendocrine carcinoma.

Histopathology·2026
Same journal

Malignant adenomyoepithelioma of the breast: seven cases illustrating morphological diversity and diagnostic challenges.

Histopathology·2026
Same journal

A CRX-positive RB1-deficient bone tumour with a retinoblastoma-like DNA methylation profile.

Histopathology·2026
Same journal

Perivascular epithelioid cell tumours of the genitourinary tract: clinicopathological features and molecular landscape.

Histopathology·2026
Same journal

Navigating diagnostic challenges in low-grade spindle cell lesions of the breast: a retrospective review.

Histopathology·2026
Same journal

Neoplastic transformation of sporadic gastric hyperplastic polyps: a systematic review and meta-analysis of risk factors and clinicopathological features.

Histopathology·2026
See all related articles

Area of Science:

  • Public Health
  • Oncology
  • Radiology

Background:

  • The UK established a national breast screening program following the 1986 Forrest Report.
  • The program targets women aged 50-64 for mammographic screening every three years.

Purpose of the Study:

  • Outline the organizational and logistical requirements for the UK's national breast screening program.
  • Highlight the impact on pathology services and the need for quality assurance.

Main Methods:

  • Implementation of a national mammographic screening program for women aged 50-64.
  • Establishment of basic screening units and specialist assessment centers.
  • Development of a national quality assurance scheme, including pathology data validation.

Related Experiment Videos

Main Results:

  • The program requires careful planning, interdisciplinary cooperation, and significant resources for pathology laboratories.
  • Pathologists will play a key role in interpreting diagnostic samples from screening, including fine needle aspiration cytology and needle localization biopsies.
  • Specialized training is necessary to address diagnostic challenges in screen-detected abnormalities.

Conclusions:

  • Successful implementation necessitates robust organizational structures, adequate funding, and specialized training for healthcare professionals.
  • A national quality assurance scheme is crucial for validating pathology data and ensuring program efficacy.
  • Close collaboration between specialties, particularly pathology, is essential for the program's success.